Date Published

December 12, 2025

Updated For

ALS PCS Version 5.2

#SWORBHPTips

What is ASA?​

  • Paramedics administer ASA to patients experiencing signs and symptoms of cardiac ischemia ​
  • ASA works by inhibiting cyclooxygenase enzymes (mainly COX-1 and COX-2)​
    • COX-1 produces Thromboxane A-2 which causes platelet aggregation (clotting)​
      • Therefore ASA inhibits platelet aggregation​
  • With ASA circulating throughout the bloodstream the chances of a new clot forming or an old clot growing is decreased.

What if the patient has already had ASA administered?

  • According to the ISIS-2 trial (Lancet, 1988), ASA decreased the mortality in patients experiencing ACS by 23%​
  • Due to the benefits of ASA in patients experiencing symptoms of cardiac ischemia, your patient may still benefit from ASA administration, even if it was administered prior to your arrival​
  • This may include patient or family self-administration, or healthcare clinic or office administration

Rationale for more ASA​

  • Ensures the patient gets the appropriate dose of ASA​
    • Was the dose taken expired?​
    • Was it truly ASA?​
  • No harm in getting an extra dose​
    • Therapeutic dosing may be up to 1500mg (that is 18 tablets of 80-81mg ASA). From OBHG Companion Document:

Summary​

  • ASA has been found to decrease mortality and is therefore a helpful treatment in suspected cardiac ischemia ​
  • Paramedics are encouraged to provide ASA even if the patient has already had this medication administered​
    • Rationale: ​
      • You ensure the patient gets the dose and medication we know helps save lives in cardiac ischemia​
      • The therapeutic range (1500mg) is far above what an additional dose (or two!) would be​
    • This includes patient self-administration as well as healthcare provider administered ASA

Categories

Additional Resources:

No additional resources available for this #SWORBHPTip.

Share this tip with others:

Select a platform: